Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Surgery Type & End-User The global surgical robots market will witness a robust CAGR of 16.84%, valued at $5.16 billion in 2021, expected to appreciate and reach $20.98 billion by 2030, confirms Strategic Market Research. North America currently has the largest market share by region, with a valuation of around USD 3.27 billion. Surgical robots assist doctors in performing many complex surgeries with more flexibility, precision, and control than conventional techniques. An estimated 1638 surgical robots will be used for various applications in 2022. Surgical robots are mostly used in minimally invasive surgeries and sometimes in traditional open surgeries. As per the Agency for Healthcare Research and Quality, more than 450,000 total hip replacements are performed annually in the USA, thereby augmenting the market's overall growth. Key Market Drivers - Advantages of Robotic-Assisted Surgery (RAS), High success rate of RAS, and Minimum Life-Threatening Complications The demand for minimally invasive (MI) surgical procedures is increasing due to a plethora of advantages associated with these procedures, such as smaller incisions, reduced pain, decreased scarring, faster recovery periods, increased safety, and considerable cost savings. According to a study, the average recovery time for a patient undergoing minimally invasive spine surgery is six weeks, as compared to 12 weeks after undergoing traditional open spine surgery. In addition, robotic minimally invasive surgery ensures repeatability, accuracy, efficiency, and control, positively boosting the surgical robots market trends in robotic surgery. The robotic-assisted surgery registered a high success rate, leading to increased adoption of surgical robots. According to NCBI, the published data about the various robot-assisted surgeries showed excellent results & success rates, ranging between (94% and 100)%. This high success rate enables more end-users to adopt surgical robots, thus driving industry growth. The robotic-assisted surgery was also found to cause minimal life-threatening complications. 2021 robotic surgery statistics show that life-threatening complications rose only from 0 to 2% in robotic-assisted surgeries. These minimal life-threatening complications from robotic surgeries allowed more end-users to adopt surgical robots, thus increasing the overall surgical robots market share. Market Restraints - High costs of Robotic-assisted Surgeries Robotic-assisted surgeries cost more than minimally invasive surgeries. The American Congress of Obstetricians & Gynaecologists has found out that the adoption of robotic surgical procedures for all hysterectomies (surgical removal of the uterus, ovaries, cervix, and Fallopian tubes) would add around USD 960 million to the annual hysterectomy costs in the United States of America. In addition to costs for adopting robotic surgical procedures, maintenance costs and declining hospital budgets have slowed down the robotic surgery market growth. Market Opportunities - Increasing Penetration of Surgical Robots in ASCs, Newer Applications for Robotic-Assisted Surgeries Ambulatory surgical centers (ASCs) are free-standing facilities specializing in diagnostic, surgical, and preventive procedures that do not require hospital admission. A Healthcare BlueBook and HealthSmart study revealed that ASCs decreased outpatient surgery costs by USD 38 billion annually since they offer a low-cost care site compared to a regular hospital’s outpatient department. According to a study, more than 9000 ambulatory surgical centers are currently operating in the US. The increasing number of ASCs will increase the adoption of surgical robots, thus fostering industry growth worldwide. Robotic-Assisted surgery has found newer applications recently. For example, robotic-arm assisted knee resurfacing, robotic heart surgery, robotic bladder surgery, robotic surgery for prostate cancer, minimally invasive neurosurgery, gynecologic surgery, endometriosis, thoracic surgery, and urologic surgery can all be done by surgical robots. This is expected to increase the overall size of the orthopedic, spinal, abdominal, and AI-based surgical robots market, respectively. Market Analysis Of Different Segments Covered in the Report Based on Application Orthopedics Neurology Urology Gynecology General Surgery Others Based on End-User Hospitals Ambulatory Surgical Centres Others Regional Coverage Analysis North America Canada United States of America Rest of North America Europe United Kingdom Germany Italy France Spain Russia Rest of Europe Asia-Pacific Australia China Japan India South Korea Singapore Rest of Asia-Pacific LAMEA Brazil Argentina South Africa Saudi Arabia United Arab Emirates Rest of LAMEA Segments Analysis & Insights The ‘General Surgery’ segment had the largest industry share by application, with around 29% in 2021. Due to the increasing use of surgical robots for cancer treatment and increasing demand for minimally invasive laparoscopic surgeries, the general surgery segment has captured a large market share. According to an NCBI study, nearly 60% of laparoscopic surgeries are performed using robots, which is expected to increase over time. The ‘hospital’ segment had the largest market share by end-user, with around 71.22%. The rising number of inpatient visits and the increasing number of surgical procedures drove the market growth in this segment. According to an NCBI study, 23 of 73 hospitals have performed robotic-assisted surgery, which is expected to rise. Due to the large US surgical robotics market size, North America had the largest share by region, valuing around USD 3.27 billion in 2022. The increasing availability of surgical robots, coupled with the growing number of injuries and diseases requiring surgery, is increasing in North America, which assists in driving the industry's growth. The European market is valued at around USD 2.17 billion in 2022. On the other hand, the Asia-Pacific region will be the fastest-growing industry, with a CAGR of 23.32% throughout the projected period. The rapidly developing technology in surgical robotics and the increasing patient population in developing markets like India and China have fostered segment growth. According to Intuitive Surgical, there are 170 da Vinci surgical robots in China that have performed over 170,000 surgeries. Surgical Robots Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 5.16 billion The revenue forecast in 2028 USD 20.98 billion Growth rate CAGR of approximately 16.84% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Application, End-Use, and Region By Application Orthopedics, Neurology, Urology, Gynaecology, General Surgery, Others By End-Use Hospitals, Ambulatory Surgical Centres By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Germany, United Kingdom, Italy, France, Spain, Russia, Canada, Australia, China, Japan, India, South Korea, Singapore, Brazil, Argentina, Saudi Arabia, United Arab Emirates, South Africa Company Usability Profiles Intuitive Surgical, Stryker Corporation, Medtronic, Smith & Nephew, Zimmer Biomet, Asensus Surgical (Transenterix), Corindus Vascular Robotics, Renishaw, Auris Health, Medrobotics Corporation, Think Surgical, Verb Surgical (part of Johnson and Johnson), OMNIlife Science, CMR Surgical, Preceyes BV, China National Scientific Instruments, and Materials Corporation, Microsure, Titan Medical, avateramedical GmbH, Medicaroid Corporation Global Surgical Robots Market Competitive Landscape Analysis The main companies in the industry mainly focus on new technology development and the introduction of next-generation robotic surgical instruments to help maintain their position in the market. In addition, the increasing demand for surgical robots will also facilitate the entry of new entrants into the market environment. Moreover, strategic industrial developments by leading competitors like mergers & acquisitions and collaborations are expected to boost the competition in the future. Intuitive Surgical (market share around 80% in 2022) Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Asensus Surgical (Transenterix) Corindus Vascular Robotics Renishaw Auris Health Medrobotics Corporation Think Surgical Verb Surgical (part of Johnson and Johnson) OMNIlife Science CMR Surgical Preceyes BV China National Scientific Instruments and Materials Corporation Microsure Titan Medical avateramedical GmbH Medicaroid Corporation Industry Recent Developments In January 2021, Stryker announced its acquisition of OrthoSensor, Inc. Stryker believes that OrthoSensor’s acquisition would allow it to implement the Verasense intraoperative sensor technology to empower its Mako robots that would allow surgeons to access more comprehensive data-driven solutions. In January 2021, TransEnterix announced receiving CE mark approval for its Intelligent Surgical Unit that enables machine vision capabilities on the Senhance Surgical System. This approval is expected to provide Senhancelaparoscopic programs in Europe, including access to this new technology, thus propelling them to the forefront of surgical innovation through augmented intelligence. In November 2020, Johnson and Johnson announced the launch of its surgical robot, Ottava. The surgical robotics are equipped with six arms to provide more control and flexibility in surgery and will be integrated with the operating table. Additionally, Johnson and Johnson acquired Verb, Inc., during its partnership with Google to design and manufacture surgical robots in 2019. In September 2020, Stryker announced the installation of its 1000th Mako robot. Stryker believes this installation will help more patients obtain treatment for their total hip, knee, and partial knee problems. Various Surgical Robots that Key Market Leaders Develop. Name of the Product Function Key Player Versius+ Used for Minimal Access Surgery CMR Surgical Mako Used for Joint Replacement Surgery Stryker Corporation Da Vinci Used for Minimally Invasive Surgery Intuitive Surgical Hugo RAS system Portable and Modular system that allows surgery to be performed on any patient using any procedure and in any operating room Medtronic Frequently Asked Question About This Report How big is the surgical robots market? The global surgical robots market size was $5.16 billion in 2021 and is expected to reach $20.98 billion in 2030, with a CAGR of 16.84%. What companies make surgical robots? The surgical robot manufacturers include: Intuitive Surgical, Stryker Corporation, Medtronic, Smith & Nephew, Zimmer Biomet, Asensus Surgical (Transenterix), Corindus Vascular Robotics, Renishaw, Auris Health, Medrobotics Corporation, Think Surgical, Verb Surgical (part of Johnson and Johnson), OMNIlife Science, CMR Surgical, Preceyes BV, China National Scientific Instruments And Materials Corporation (CSIMC), Microsure, Titan Medical, avateramedical Gmbh and Medicaroid Corporation. How many surgical robots are there? There are an estimated 1638 surgical robots currently in use. What is the surgical robots market growth? The global surgical robots market is expected to grow at a compound annual growth rate (CAGR) of 16.84% from 2021 to 2030 to reach USD 20.98 billion by 2030. What are the current trends in surgical robotics? The advantages of robotic-assisted surgery, high success rate and minimum life-threatening conditions due to RAS are the latest trends in surgical robotics. What are the future trends in the surgical robotics market? The increasing penetration of robotic-assisted surgery and newer applications for surgical robots can help the market grow further. How many surgical robots are there in the world? There are an estimated 1638 surgical robots currently in the world. Is robotic surgery growing? Yes, the robotic surgery market is growing, with a CAGR of 16.84% Sources https://orthoinfo.aaos.org/en/treatment/total-hip-replacement/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104663/ https://www.chinadaily.com.cn/a/202011/06/WS5fa4e9bba31024ad0ba838f5.html https://investors.stryker.com/press-releases/news-details/2021/Stryker-acquires-OrthoSensor/default.aspx 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Surgical Robots Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Surgical Robots Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021-2030 (USD Million) 4.4 End-User Business Analysis 4.4.1 Market, By End-User, 2021-2030 (USD Million) 4.5 Application Business Analysis 4.5.1 Market, By Application, 2021-2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Application Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Orthopaedics 7.3.1. Orthopaedics, Market, 2021-2030 (USD Million) 7.4. Neurology 7.4.1. Neurology, Market, 2021-2030 (USD Million) 7.5. Urology 7.5.1. Urology, Market, 2021-2030 (USD Million) 7.6. Gynaecology 7.6.1. Gynaecology, Market, 2021-2030 (USD Million) 7.7. General Surgery 7.7.1. General Surgery, Market, 2021-2030 (USD Million) 7.8. Others 7.8.1. Others, Market, 2021-2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Ambulatory Surgical Centres 8.4.1. Ambulatory Surgical Centres market, 2021-2030 (USD Million) 8.5 Others 8.5.1 Others market, 2021-2030 (USD Million) 9. Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By End-User, 2021-2030 (USD Million) 9.1.4. North America Market, By Application, 2021-2030 (USD Million) 9.1.5. North America Market, by Country, 2021-2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By End-User, 2021-2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By End-User, 2021-2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021-2030 (USD Million) 9.1.4.2.3. Canada Market, by Applications, 2021-2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By End-User, 2021-2030 (USD Million) 9.2.2. Europe Market, by By Application, 2021-2030 (USD Million) 9.2.5. Europe Market, by country, 2021-2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By End-User, 2021-2030 (USD Million) 9.2.4.1.2. U.K. Market, By Applications, 2021-2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021-2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By End-User, 2021-2030 (USD Million) 9.2.4.2.2. Germany Market, By Application, 2021-2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021-2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By End-User, 2021-2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021-2030 (USD Million) 9.2.4.3.3. France Market, by Application, 2021-2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By End-User, 2021-2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021-2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by Application, 2021-2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 9.3.2. Asia Pacific Market, By Application, 2021-2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021-2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By End-User, 2021-2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021-2030 (USD Million) 9.3.4.1.3. China Market, by Application, 2021-2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By End-User, 2021-2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021-2030 (USD Million) 9.3.4.2.3. India Market, by Application, 2021-2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By End-User, 2021-2030 (USD Million) 9.3.4.3.3. Japan Market, by Application, 2021-2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By End-User, 2021-2030 (USD Million) 9.3.4.4.3. South Korea Market, by Application, 2021-2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021-2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By End-User, 2021-2030 (USD Million) 9.4.3. Latin America Market, by Application, 2021-2030 (USD Million) 9.4.4. Latin America Market, by country, 2021-2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By End-User, 2021-2030 (USD Million) 9.4.4.1.3. Brazil Market, by Application, 2021-2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By End-User, 2021-2030 (USD Million) 9.4.4.2.3. Mexico Market, by Application, 2021-2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By End-User, 2021-2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by Application, 2021-2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By End-User, 2021-2030 (USD Million) 9.5.3. MEA Market, by Application, 2021-2030 (USD Million) 10. Competitive Landscape 10.1 Intuitive Surgical. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. ProductPortfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Stryker Corporation 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Medtronic. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Smith & Nephew. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Zimmer Biomet 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Asensus Surgical (Transenterix). 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Corindus Vascular Robotics. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Renishaw. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Auris Health. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Medrobotics Corporation. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Think Surgical. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. Verb Surgical. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. OMNIlife Science. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. CMR Surgical. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. Preceyes BV. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 10.16. China National Scientific Instruments and Materials Corporation 10.16.1. Company overview 10.16.2. Financial performance 10.16.3. Product Portfolio Analysis 10.16.4. Business Strategy & Recent Development 10.17. Microsure. 10.17.1. Company overview 10.17.2. Financial performance 10.17.3. Product Portfolio Analysis 10.17.4. Business Strategy & Recent Development 10.18. Titan Medical. 10.18.1. Company overview 10.18.2. Financial performance 10.18.3. Product Portfolio Analysis 10.18.4. Business Strategy & Recent Development 10.19. Avateramedical GmbH. 10.19.1. Company overview 10.19.2. Financial performance 10.19.3. Product Portfolio Analysis 10.19.4. Business Strategy & Recent Development 10.20. Medicaroid Corporation. 10.20.1. Company overview 10.20.2. Financial performance 10.20.3. Product Portfolio Analysis 10.20.4. Business Strategy & Recent Development List of Tables (67 Tables) TABLE 1. MARKET, By Application, 2021-2030 (USD Million) TABLE 2. MARKET FOR Orthopaedics, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Neurology, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Urology, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Gynaecology, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR General Surgery, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY End-User, 2021-2030 (USD Million) TABLE 9. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Ambulatory Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 12. Market, BY REGION, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, BY Applications, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 17. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 18. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 19. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 23. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 25. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 26. Intuitive Surgical: COMPANY SNAPSHOT TABLE 27. Intuitive Surgical: OPERATING SEGMENTS TABLE 28. Stryker Corporation: COMPANY SNAPSHOT TABLE 29. Stryker Corporation: OPERATING SEGMENTS TABLE 30. Medtronic: COMPANY SNAPSHOT TABLE 31. Medtronic: OPERATING SEGMENTS TABLE 32. Smith & Nephew: COMPANY SNAPSHOT TABLE 33. Smith & Nephew: OPERATING SEGMENTS TABLE 34. Zimmer Biomet: COMPANY SNAPSHOT TABLE 35. Zimmer Biomet: OPERATING SEGMENTS TABLE 36. Asensus Surgical (Transenterix): COMPANY SNAPSHOT TABLE 37. Asensus Surgical (Transenterix): OPERATING SEGMENTS TABLE 38. Corindus Vascular Robotics: COMPANY SNAPSHOT TABLE 39. Corindus Vascular Robotics: OPERATING SEGMENTS TABLE 40. Renishaw: COMPANY SNAPSHOT TABLE 41. Renishaw: OPERATING SEGMENTS TABLE 42. Auris Health: COMPANY SNAPSHOT TABLE 43. Auris Health: OPERATING SEGMENTS TABLE 44. Medrobotics Corporation: COMPANY SNAPSHOT TABLE 45. Medrobotics Corporation: OPERATING SEGMENTS TABLE 46. Think Surgical: COMPANY SNAPSHOT TABLE 47. Think Surgical: OPERATING SEGMENTS TABLE 48. Verb Surgical.: COMPANY SNAPSHOT TABLE 49. Verb Surgical.: OPERATING SEGMENTS TABLE 50. OMNIlife Science: COMPANY SNAPSHOT TABLE 51. OMNIlife Science: OPERATING SEGMENTS TABLE 52. CMR Surgical: COMPANY SNAPSHOT TABLE 53. CMR Surgical: OPERATING SEGMENTS TABLE 54. Preceyes BV: COMPANY SNAPSHOT TABLE 55. Preceyes BV: OPERATING SEGMENTS TABLE 56. China National Scientific Instruments and Materials Corporation: COMPANY SNAPSHOT TABLE 57. China National Scientific Instruments and Materials Corporation: OPERATING SEGMENTS TABLE 58. Microsure: COMPANY SNAPSHOT TABLE 59. Microsure: OPERATING SEGMENTS TABLE 60. Titan Medical: COMPANY SNAPSHOT TABLE 61. Titan Medical: OPERATING SEGMENTS TABLE 62. Avateramedical GmbH: COMPANY SNAPSHOT TABLE 63. Avateramedical GmbH: OPERATING SEGMENTS TABLE 64. Medicaroid Corporation: COMPANY SNAPSHOT TABLE 65. Medicaroid Corporation: OPERATING SEGMENTS TABLE 66. Sebbin: COMPANY SNAPSHOT TABLE 67. Sebbin: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 20 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Surgical Robots, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Surgical Robots, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Applications, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-User, 2019 vs. 2025 Figure 13 Geographical Snapshot of the Market Figure 14 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 15 General Surgery to Witness Higher CAGR in the Market for Application Segment during the Forecast Period. Figure 16 Asia-Pacific Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview